https://pmsf.org/conference/
- Forums
- ASX - By Stock
- NEU
- Ann: P2 trial shows significant improvements in Phelan-McDermid
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.24%
!
$12.54

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-208
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
-0.420(3.24%) |
Mkt cap ! $1.574B |
Open | High | Low | Value | Volume |
$12.82 | $13.05 | $12.53 | $4.896M | 381.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 783 | $12.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.55 | 814 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 28 | 12.590 |
7 | 1985 | 12.580 |
4 | 671 | 12.570 |
8 | 4924 | 12.560 |
7 | 4385 | 12.550 |
Price($) | Vol. | No. |
---|---|---|
12.600 | 415 | 8 |
12.610 | 1248 | 11 |
12.620 | 1922 | 15 |
12.630 | 4002 | 9 |
12.640 | 1532 | 5 |
Last trade - 15.26pm 17/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online